Printer Friendly
The Free Library
22,741,889 articles and books

Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.



BALA CYNWYD, Pa., July 17, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 announces that it is investigating potential claims against the Board of Directors of Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. , Inc. ("Human Genome" or the "Company")(Nasdaq- HGSI HGSI Human Genome Sciences, Inc. (Rockville, MD) ) relating to the proposed acquisition by GlaxoSmithKline plc. ("GSK GSK GlaxoSmithKline plc (pharmaceutical company)
GSK Glycogen Synthase Kinase
GSK Gruppentraining Sozialer Kompetenzen (Germany)
GSK Greenland Shark (FAO fish species code) 
").

Under the terms of the transaction, Human Genome shareholders will receive only $14.25 in cash for each of Human Genome stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Human Genome for not acting in the Company's shareholders' best interests in connection with the sale process to GSK. The transaction may undervalue the Company as Human Genome stock traded at $29.60 a share on April 28, 2011 and traded at $14.59 a share as recently as April 26, 2012. In addition, an analyst has set a price target on Human Genome stock at $23.00 per share and sales of Human Genome's new lupus drug BENLYSTA reached $31.2 million for the first quarter of 2012.

If you own shares of Human Genome stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/453-hgsi-human-genome-sciences-inc.html, or by calling toll free 877-LEGAL-90.

SOURCE Brodsky & Smith, LLC
COPYRIGHT 2012 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 17, 2012
Words:335
Previous Article:SAIC To Acquire maxIT Healthcare.
Next Article:Ronald Reagan UCLA Medical Center Rated One Of Top Hospitals In The U.S.
Topics:

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters